Newly Identified Loci That Influence Lipid Concentrations and Risk of Coronary Artery Disease

To identify genetic variants influencing plasma lipid concentrations, we first used genotype imputation and meta-analysis to combine three genome-wide scans totaling 8,816 individuals and comprising 6,068 individuals specific to our study (1,874 individuals from the FUSION study of type 2 diabetes and 4,184 individuals from the SardiNIA study of aging-associated variables) and 2,758 individuals from the Diabetes Genetics Initiative, reported in a companion study in this issue. We subsequently examined promising signals in 11,569 additional individuals. Overall, we identify strongly associated variants in eleven loci previously implicated in lipid metabolism (ABCA1, the APOA5-APOA4-APOC3-APOA1 and APOE-APOC clusters, APOB, CETP, GCKR, LDLR, LPL, LIPC, LIPG and PCSK9) and also in several newly identified loci (near MVK-MMAB and GALNT2, with variants primarily associated with high-density lipoprotein (HDL) cholesterol; near SORT1, with variants primarily associated with low-density lipoprotein (LDL) cholesterol; near TRIB1, MLXIPL and ANGPTL3, with variants primarily associated with triglycerides; and a locus encompassing several genes near NCAN, with variants strongly associated with both triglycerides and LDL cholesterol). Notably, the 11 independent variants associated with increased LDL cholesterol concentrations in our study also showed increased frequency in a sample of coronary artery disease cases versus controls.

Citing Articles

Causal relationship between drug target genes of LDL-cholesterol and coronary artery disease: drug target Mendelian randomization study.

Jee Y, Shin J, Ryu M, Song T Lipids Health Dis. 2025; 24(1):92.

PMID: 40082904 PMC: 11905656. DOI: 10.1186/s12944-025-02502-z.

A Comprehensive Review of the Genetics of Dyslipidemias and Risk of Atherosclerotic Cardiovascular Disease.

Kalwick M, Roth M Nutrients. 2025; 17(4).

PMID: 40004987 PMC: 11858766. DOI: 10.3390/nu17040659.

Genetic and Epigenetic Intersections in COVID-19-Associated Cardiovascular Disease: Emerging Insights and Future Directions.

Sabit H, Arneth B, Altrawy A, Ghazy A, Abdelazeem R, Adel A Biomedicines. 2025; 13(2).

PMID: 40002898 PMC: 11852909. DOI: 10.3390/biomedicines13020485.

Alzheimer's disease: a comprehensive review of epidemiology, risk factors, symptoms diagnosis, management, caregiving, advanced treatments and associated challenges.

Safiri S, Ghaffari Jolfayi A, Fazlollahi A, Morsali S, Sarkesh A, Daei Sorkhabi A Front Med (Lausanne). 2024; 11:1474043.

PMID: 39736972 PMC: 11682909. DOI: 10.3389/fmed.2024.1474043.

Associations of Blood Lipid-Related Polygenic Scores, Lifestyle Factors and Their Combined Effects with Risk of Coronary Artery Disease in the UK Biobank Cohort.

Choi J, Wen W, Jia G, Tao R, Long J, Shu X J Cardiovasc Transl Res. 2024; .

PMID: 39680354 DOI: 10.1007/s12265-024-10578-8.

References

Scott L, Mohlke K, Bonnycastle L, Willer C, Li Y, Duren W . A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 2007; 316(5829):1341-5. PMC: 3214617. DOI: 10.1126/science.1142382. View

Nielsen M, Jacobsen C, Olivecrona G, GLIEMANN J, Petersen C . Sortilin/neurotensin receptor-3 binds and mediates degradation of lipoprotein lipase. J Biol Chem. 1999; 274(13):8832-6. DOI: 10.1074/jbc.274.13.8832. View

Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D . The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med. 2004; 164(21):2335-42. DOI: 10.1001/archinte.164.21.2335. View

Romeo S, Pennacchio L, Fu Y, Boerwinkle E, Tybjaerg-Hansen A, Hobbs H . Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat Genet. 2007; 39(4):513-6. PMC: 2762948. DOI: 10.1038/ng1984. View

Kiss-Toth E, Bagstaff S, Sung H, Jozsa V, Dempsey C, Caunt J . Human tribbles, a protein family controlling mitogen-activated protein kinase cascades. J Biol Chem. 2004; 279(41):42703-8. DOI: 10.1074/jbc.M407732200. View

George V, Elston R . Testing the association between polymorphic markers and quantitative traits in pedigrees. Genet Epidemiol. 1987; 4(3):193-201. DOI: 10.1002/gepi.1370040304. View

Law M, Wald N, Rudnicka A . Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ. 2003; 326(7404):1423. PMC: 162260. DOI: 10.1136/bmj.326.7404.1423. View

Saxena R, Voight B, Lyssenko V, Burtt N, de Bakker P, Chen H . Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science. 2007; 316(5829):1331-6. DOI: 10.1126/science.1142358. View

Kuivenhoven J, Pritchard H, Hill J, Frohlich J, Assmann G, Kastelein J . The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes. J Lipid Res. 1997; 38(2):191-205. View

10.

Magrane J, Casaroli-Marano R, Reina M, Gafvels M, Vilaro S . The role of O-linked sugars in determining the very low density lipoprotein receptor stability or release from the cell. FEBS Lett. 1999; 451(1):56-62. DOI: 10.1016/s0014-5793(99)00494-9. View

11.

Pilia G, Chen W, Scuteri A, Orru M, Albai G, Dei M . Heritability of cardiovascular and personality traits in 6,148 Sardinians. PLoS Genet. 2006; 2(8):e132. PMC: 1557782. DOI: 10.1371/journal.pgen.0020132. View

12.

Kathiresan S, Melander O, Guiducci C, Surti A, Burtt N, Rieder M . Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet. 2008; 40(2):189-97. PMC: 2682493. DOI: 10.1038/ng.75. View

13.

Naoumova R, Tosi I, Patel D, Neuwirth C, Horswell S, Marais A . Severe hypercholesterolemia in four British families with the D374Y mutation in the PCSK9 gene: long-term follow-up and treatment response. Arterioscler Thromb Vasc Biol. 2005; 25(12):2654-60. DOI: 10.1161/01.ATV.0000190668.94752.ab. View

14.

. Caerphilly and Speedwell collaborative heart disease studies. The Caerphilly and Speedwell Collaborative Group. J Epidemiol Community Health. 1984; 38(3):259-62. PMC: 1052363. DOI: 10.1136/jech.38.3.259. View

15.

Hercberg S, Preziosi P, Briancon S, Galan P, Triol I, Malvy D . A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study--design, methods, and participant characteristics. SUpplementation en.... Control Clin Trials. 1998; 19(4):336-51. DOI: 10.1016/s0197-2456(98)00015-4. View

16.

Chen W, Abecasis G . Family-based association tests for genomewide association scans. Am J Hum Genet. 2007; 81(5):913-26. PMC: 2265659. DOI: 10.1086/521580. View

17.

Lind S, Olsson A, Eriksson M, Rudling M, Eggertsen G, Angelin B . Autosomal recessive hypercholesterolaemia: normalization of plasma LDL cholesterol by ezetimibe in combination with statin treatment. J Intern Med. 2004; 256(5):406-12. DOI: 10.1111/j.1365-2796.2004.01401.x. View

18.

Nordestgaard B, Benn M, Schnohr P, Tybjaerg-Hansen A . Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007; 298(3):299-308. DOI: 10.1001/jama.298.3.299. View

19.

Pare G, Serre D, Brisson D, Anand S, Montpetit A, Tremblay G . Genetic analysis of 103 candidate genes for coronary artery disease and associated phenotypes in a founder population reveals a new association between endothelin-1 and high-density lipoprotein cholesterol. Am J Hum Genet. 2007; 80(4):673-82. PMC: 1852704. DOI: 10.1086/513286. View

20.

Post W, Shen H, Damcott C, Arking D, Kao W, Sack P . Associations between genetic variants in the NOS1AP (CAPON) gene and cardiac repolarization in the old order Amish. Hum Hered. 2007; 64(4):214-9. PMC: 2880727. DOI: 10.1159/000103630. View